Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PowerShares Variable Rate Investment Grade Portfolio | VRIG | Oct 31, 2024 | 25.09 | -0.02 |
PowerUp Acquisition A | PWUP | Oct 31, 2024 | 11.44 | 0.00 |
PowerUp Acquisition Unit | PWUPU | Oct 31, 2024 | 11.44 | 0.00 |
PPG Industries | PPG | Oct 31, 2024 | 124.51 | -0.92 |
PPL | PPL | Oct 31, 2024 | 32.56 | +0.99 |
PRA Group | PRAA | Oct 31, 2024 | 20.16 | +0.85 |
Prairie Operating | PROP | Oct 31, 2024 | 8.35 | -1.30 |
Praxis Precision Medicines | PRAX | Oct 31, 2024 | 69.99 | -0.05 |
Precigen | PGEN | Oct 31, 2024 | 0.79 | -4.30 |
Precipio | PRPO | Oct 31, 2024 | 6.41 | -1.08 |
Precision BioSciences | DTIL | Oct 31, 2024 | 8.56 | +6.07 |
Precision Drilling | PDS | Oct 31, 2024 | 60.05 | -1.83 |
Precision Optics | POCI | Oct 31, 2024 | 3.80 | +0.80 |
Predictive Oncology | POAI | Oct 31, 2024 | 0.72 | -4.37 |
Preferred Bank | PFBC | Oct 31, 2024 | 84.37 | -1.37 |
Preferred Portfolio Powershares | PGX | Oct 31, 2024 | 12.07 | -0.49 |
Preformed Line Products | PLPC | Oct 31, 2024 | 123.00 | -0.35 |
Prelude Therapeutics | PRLD | Oct 31, 2024 | 1.20 | -9.09 |
Premier A | PINC | Oct 31, 2024 | 20.15 | -0.64 |
Premier Financial | PFC | Oct 31, 2024 | 24.66 | -0.64 |
Premium Catering Holdings | PC | Oct 31, 2024 | 0.67 | 0.00 |
Prenetics Global A | PRE | Oct 31, 2024 | 4.64 | 0.00 |
Presidio Property Trust A | SQFT | Oct 31, 2024 | 0.70 | +2.22 |
Presidio Property Trust D Pref | SQFTP | Oct 31, 2024 | 14.52 | -0.85 |
Prestige Consumer Healthcare | PBH | Oct 31, 2024 | 73.75 | +0.26 |
Prestige Wealth | PWM | Oct 31, 2024 | 0.92 | +0.51 |
PriceSmart | PSMT | Oct 31, 2024 | 83.08 | -6.98 |
Prime Medicine | PRME | Oct 31, 2024 | 3.88 | -4.67 |
Primech Holdings | PMEC | Oct 31, 2024 | 0.76 | +2.70 |
PrimeEnergy Resources | PNRG | Oct 31, 2024 | 164.95 | +2.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.